(5)
Includes 31,230 shares of Common Stock subject to stock appreciation rights, of which 4,000 shares have a
grant price of $18.41, 6,400 shares have a grant price of $31.24, 7,200 shares have a grant price of $30.71,
3,600 shares have a grant price of $13.65, 7,719 shares have a grant price of $38.40, and 2,311 shares have
a grant price of $81.23, all exercisable within 60 days. Also includes 1,347 shares held indirectly through a
401(k) plan account, 591 shares of restricted stock and 9,934 restricted stock units subject to a vesting
schedule.
(6)
Includes 15,282 restricted stock units subject to a vesting schedule.
(7)
Includes 2,190 shares held indirectly through a 401(k) plan account, 1,471 shares of restricted stock and
30,605 restricted stock units subject to a vesting schedule.
(8)
Includes 3,500 shares of Common Stock subject to stock options exercisable within 60 days and 987
restricted stock units subject to a vesting schedule.
(9)
Includes 15,000 shares of Common Stock subject to stock options exercisable within 60 days and 987
restricted stock units subject to a vesting schedule.
(10) Includes 2,685 shares held indirectly by Mr. Kusin as Trustee of the Kusin Family Trust and 781 restricted
stock units subject to a vesting schedule.
(11) Consists of 259 restricted stock units subject to a vesting schedule.
(12) Includes 5,000 shares of Common Stock subject to stock options exercisable within 60 days and 987
restricted stock units subject to a vesting schedule.
(13) Includes indirect ownership of 575,442 shares of Common Stock owned of record by Healing Light
Limited, an entity controlled by Mr. Shroff. Mr. Shroff and his wife, Mrs. Pervin Shroff, share voting and
investment power with respect to 575,442 shares of Common Stock. Also includes 987 restricted stock
units subject to a vesting schedule.
(14) Includes 15,000 shares of Common Stock subject to stock options exercisable within 60 days and 987
restricted stock units subject to a vesting schedule.
(15) Includes 14,000 shares of Common Stock subject to stock options exercisable within 60 days and 987
restricted stock units subject to a vesting schedule.
(16) Includes 22,000 shares of Common Stock subject to stock options exercisable within 60 days and 987
restricted stock units subject to a vesting schedule.
(17) Includes 9,000 shares of Common Stock subject to stock options exercisable within 60 days and 987
restricted stock units subject to a vesting schedule.
(18) Reflects the information in footnotes (3) through (17) above, and includes 20 shares of Common Stock
owned by Mr. Livio Galanti as custodian for Gabriel Galanti, minor child, and 92 shares of restricted stock
and 10,491 restricted stock units subject to a vesting schedule that are owned by Mr. Galanti.
(19) Based on Schedule 13G filed on February 9, 2012 by BlackRock, Inc. ("BlackRock"), 40 East 52nd Street,
New York, New York 10022. The Schedule 13G discloses that BlackRock has the sole power to vote or
direct the vote of 3,177,289 shares of Common Stock, and sole power to dispose or to direct the disposition
of 3,177,289 shares of Common Stock.
(20) Based on Amendment No. 16 to Schedule 13G filed on February 14, 2012 by FMR LLC ("FMR"), 82
Devonshire Street, Boston, Massachusetts 02109. Amendment No. 16 discloses that FMR has the sole
power to vote or direct the vote of 27,807 of the 9,445,774 shares of Common Stock it beneficially owns,
and sole power to dispose or to direct the disposition of 9,445,774 shares of Common Stock. Amendment
No. 16 additionally discloses that Edward C. Johnson, 3d has sole dispositive power over 9,445,774 shares
of Common Stock, and Fidelity Growth Company Fund, an investment company registered under the
Investment Company Act of 1940, had an interest in 5,628,100 shares of Common Stock.
(21) Based on Amendment No. 1 to Schedule 13G filed on February 10, 2012 by T. Rowe Price Associates, Inc.
("Price Associates"), 100 E. Pratt Street, Baltimore, Maryland 21202. These securities are owned by
various individual and institutional investors (including T. Rowe Price International and the T. Rowe Price
Mutual Funds) which own 6,275,925 shares, representing 10.0% of the shares outstanding, which T. Rowe
Price Associates, Inc. ("Price Associates") serves as investment adviser with power to direct investments
and/or sole power to vote the securities. For purposes of the reporting requirements of the Exchange Act,
Price Associates is deemed to be a beneficial owner of such securities; however Price Associates expressly
disclaims that it is, in fact, the beneficial owner of such securities.
5